Clinical Trial to Assess Effect of Synbiotic Supplement on Infant Growth

G-RAFS (Growth-Rates And Feeding with Synbiotics) Study Goal: To assess the effect of a synbiotic supplement (Bifidobacterium lactis combined with a galacto-oligosaccharride) on infant growth Lead: UCSF researcher Michael Cabana, MD, MPH, Professor of Pediatrics, Epidemiology & Biostatistics, supported by the CTSI Clinical Research Center  Recruitment: Healthy newborn infants less than 14 days of age, whose parents have elected to use infant formula already, with a history of full-term gestation (> 37 weeks gestation) Questions: Call 866-913-8477 or email [email protected] Learn more